10:18am ET
Investing
3 Explosive Stocks With High Short Interest
Short interest is always a sign of how bearish investors may be on a stock. But it can also serve as a potential sign of a coming short squeeze, especially if the…
Companies
/Healthcare
Collegium Pharmaceutical Inc
$25.35
▼ $1.09 (−4.12%) today
Markets closed · 4:48am ET
Today · % change
Fundamentals
Market Cap
$819.6M
P/E Ratio
20.8
Profit Margin
5.9%
Revenue (TTM)
$808.2M
EPS (TTM)
$1.27
52-Week Range
$25 – $51
Street Target
$49.60
About Collegium Pharmaceutical
Collegium Pharmaceutical Inc specializes in creating innovative pain management medications. Their product lineup features Xtampza ER, a unique formulation designed to deter abuse while providing extended pain relief, and Nucynta, available in both extended and immediate-release versions for various pain intensities. They also offer Belbuca, a buprenorphine-based film for pain management, and Symproic, aimed at treating opioid-induced constipation in adults. Founded in 2002 and based in Stoughton, Massachusetts, Collegium is dedicated to improving the lives of people dealing with chronic pain.
